EyePoint Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

EyePoint Pharmaceuticals, Inc.

EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release…

Biotechnology
US, Watertown [HQ]

Risk Factors

By Management
Not Available

    No Risk Factor available yet. You can request "Risk Factors" through an email.

End of EYPT's Analysis
CIK: 1314102 CUSIP: 30233G209 ISIN: US30233G2093 LEI: - UEI: -
Secondary Listings
EYPT has no secondary listings inside our databases.